Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Post-Transplant Events

A prospective, randomized study of cryotherapy during administration of high-dose melphalan to decrease the severity and duration of oral mucositis in patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation

Bone Marrow Transplantation volume 37, pages 1031–1035 (2006)Cite this article

Abstract

Forty patients with multiple myeloma scheduled to receive melphalan 200 mg/m2 followed by autologous stem cell transplantation were randomly assigned to receive oral cryotherapy or room temperature normal saline rinses 30 min before and for 6 h after high-dose therapy. Patients were evaluated for the development of mucositis using the National Cancer Institute grading system as well as evaluation of secondary measures such as days of total parenteral nutrition (TPN), narcotic use, hospitalization, weight loss and resumption of oral caloric intake for 28 days after transplant. Patients self-scored their pain, swallowing, drinking, eating, sleeping and taste alterations for 28 days. The primary end point of this trial was the incidence of grades 3–4 mucositis. Compared to the normal saline group, patients using cryotherapy experienced less grade 3–4 mucositis, 14 vs 74%, P=0.0005. Patients receiving cryotherapy also had statistically lower uses of narcotics and TPN, although there were no differences in length of hospitalization or weight loss. Patient-reported pain was significantly lower and activities were significantly better in the cryotherapy group.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Sonis ST . Oral mucositis in cancer therapy (Review). J Support Oncol 2004; 2: 3–8.

    PubMed  Google Scholar 

  2. Cawley MM, Benson LM . Current trends in managing oral mucositis (Review). Clin J Oncol Nurs 2005; 9: 584–592.

    Article  Google Scholar 

  3. Gabriel DA, Shea T, Olajida O, Serody JS, Comeau T . The effect of oral mucositis on morbidity and mortality in bone marrow transplant (Review). Semin Oncol 2003; 30: 76–83.

    Article  CAS  Google Scholar 

  4. Moreau P, Facon T, Attal M, Hulin, Michallet M, Maloisel F et al. Comparison of 200 mg/m2 melphalan and 8 Gy total body irradiation plus 140 mg/m2 melphalan as conditioning regimens for peripheral blood stem cell transplantation in patients with newly diagnosed multiple myeloma: final analysis of the Intergroupe Francophone du Myélome 9502 randomized trial. Blood 2002; 99: 731–735.

    Article  CAS  Google Scholar 

  5. Bensinger WI . The role of hematopoietic stem cell transplantation in the treatment of multiple myeloma. J Natl Cooperative Cancer Network 2004; 2: 371–378.

    Article  Google Scholar 

  6. Filicko J, Lazarus HM, Flomenberg N . Mucosal injury in patients undergoing hematopoietic progenitor cell transplantation: new approaches to prophylaxis and treatment (Review). Bone Marrow Transplant 2003; 31: 1–10.

    Article  CAS  Google Scholar 

  7. Cowen D, Tardieu C, Schubert M, Peterson D, Resbeut M, Faucher C et al. Low energy Helium–Neon laser in the prevention of oral mucositis in patients undergoing bone marrow transplant: results of a double blind randomized trial. Int J Radiat Oncol Biol Phys 1997; 38: 697–703.

    Article  CAS  Google Scholar 

  8. Spencer A, Horvath N, Gibson J, Prince HM, Herrmann R, Bashford J et al. Prospective randomised trial of amifostine cytoprotection in myeloma patients undergoing high-dose melphalan conditioned autologous stem cell transplantation. Bone Marrow Transplant 2005; 35: 971–977.

    Article  CAS  Google Scholar 

  9. Mahood DJ, Dose AM, Loprinzi CL, Veeder MH, Athmann LM, Therneau TM et al. Inhibition of fluorouracil-induced stomatitis by oral cryotherapy. J Clin Oncol 1991; 9: 449–452.

    Article  CAS  Google Scholar 

  10. Rocke LK, Loprinzi CL, Lee JK, Kunselman SJ, Iverson RK, Finck G et al. A randomized clinical trial of two different durations of oral cryotherapy for prevention of 5-fluorouracil-related stomatitis. Cancer 1993; 72: 2234–2238.

    Article  CAS  Google Scholar 

  11. Meloni G, Capria S, Proia A, Trisolini SM, Mandelli F . Ice pops to prevent melphalan-induced stomatitis. Lancet 1996; 347: 1691–1692.

    Article  CAS  Google Scholar 

  12. Dumontet C, Sonnet A, Baston Y, Salles G, Espinouse D, Coiffier B . Prevention of high dose L-PAM-induced mucositis by cryotherapy. Bone Marrow Transplant 1994; 14: 492–494.

    CAS  PubMed  Google Scholar 

  13. Avritscher EB, Cooksley CD, Elting LS . Scope and epidemiology of cancer therapy-induced oral and gastrointestinal mucositis (Review). Semin Oncol Nurs 2004; 20: 3–10.

    Article  Google Scholar 

  14. Pinguet F, Martel P, Fabbro M, Petit I, Canal P, Culine S et al. Pharmacokinetics of high-dose intravenous melphalan in patients undergoing peripheral blood hematopoietic progenitor-cell transplantation. Anticancer Res 1997; 17: 605–611.

    CAS  Google Scholar 

  15. Barasch A, Peterson DE, Tanzer JM, D'Ambrosio JA, Nuki K, Schubert M et al. Helium–neon laser effects on conditioning-induced oral mucositis in bone marrow transplantation patients. Cancer 1995; 76: 2550–2556.

    Article  CAS  Google Scholar 

  16. Aquino VM, Harvey AR, Garvin JH, Godder KT, Nieder ML, Adams RH et al. A double-blind randomized placebo-controlled study of oral glutamine in the prevention of mucositis in children undergoing hematopoietic stem cell transplantation: a pediatric blood and marrow transplant consortium study. Bone Marrow Transplant 2005; 36: 611–616.

    Article  CAS  Google Scholar 

  17. Spielberger R, Stiff P, Bensinger W, Gentile T, Weisdorf D, Kewalramani T et al. Palifermin for oral mucositis after intensive therapy for hematologic cancers. N Engl J Med 2004; 351: 2590–2598.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported by Friends of Jose Carreras International Leukemia Foundation Presidential Award, NCI P01 CA-18029.

Author information

Authors and Affiliations

  1. Fred Hutchinson Cancer Research Center, the Seattle Cancer Care Alliance and the University of Washington, Seattle, WA, USA

    K Lilleby, P Garcia, T Gooley, P McDonnnell, R Taber, L Holmberg, D G Maloney, O W Press & W Bensinger

Authors
  1. K Lilleby
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P Garcia
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. T Gooley
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. P McDonnnell
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. R Taber
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. L Holmberg
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. D G Maloney
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. O W Press
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. W Bensinger
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to W Bensinger.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lilleby, K., Garcia, P., Gooley, T. et al. A prospective, randomized study of cryotherapy during administration of high-dose melphalan to decrease the severity and duration of oral mucositis in patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 37, 1031–1035 (2006). https://doi.org/10.1038/sj.bmt.1705384

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1705384

Keywords

This article is cited by

Search

Advanced search

Quick links